These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36494342)

  • 1. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.
    Berastegui N; Ainciburu M; Romero JP; Garcia-Olloqui P; Alfonso-Pierola A; Philippe C; Vilas-Zornoza A; San Martin-Uriz P; Ruiz-Hernández R; Abarrategi A; Ordoñez R; Alignani D; Sarvide S; Castro-Labrador L; Lamo-Espinosa JM; San-Julian M; Jimenez T; López-Cadenas F; Muntion S; Sanchez-Guijo F; Molero A; Montoro MJ; Tazón B; Serrano G; Diaz-Mazkiaran A; Hernaez M; Huerga S; Bewicke-Copley F; Rio-Machin A; Maurano MT; Díez-Campelo M; Valcarcel D; Rouault-Pierre K; Lara-Astiaso D; Ezponda T; Prosper F
    Nat Commun; 2022 Dec; 13(1):7619. PubMed ID: 36494342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyserythropoiesis of myelodysplastic syndromes.
    Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
    Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
    Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
    Elife; 2023 Jan; 12():. PubMed ID: 36629404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of DNA-damage-inducible transcript 3 promoter is a common event in patients with myelodysplastic syndrome.
    Lin J; Wang YL; Qian J; Yao DM; Zhu ZH; Qian Z; Xu WR
    Leuk Res; 2010 Aug; 34(8):991-4. PubMed ID: 20116099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
    Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
    PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
    Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyserythropoiesis in myelodysplastic syndrome].
    Iwama A
    Rinsho Ketsueki; 2018; 59(10):2036-2041. PubMed ID: 30305506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndrome hematopoietic stem cell.
    Li J
    Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
    Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
    Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs.
    Yokomizo-Nakano T; Hamashima A; Kubota S; Bai J; Sorin S; Sun Y; Kikuchi K; Iimori M; Morii M; Kanai A; Iwama A; Huang G; Kurotaki D; Takizawa H; Matsui H; Sashida G
    J Exp Med; 2023 Jul; 220(7):. PubMed ID: 37071125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2AX deficiency is associated with erythroid dysplasia and compromised haematopoietic stem cell function.
    Zhao B; Tan TL; Mei Y; Yang J; Yu Y; Verma A; Liang Y; Gao J; Ji P
    Sci Rep; 2016 Jan; 6():19589. PubMed ID: 26791933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome.
    Dong XM; Zhao K; Zheng WW; Xu CW; Zhang MJ; Yin RH; Gao R; Tang LJ; Liu JF; Chen H; Zhan YQ; Yu M; Ge CH; Gao HY; Li X; Luo T; Ning HM; Yang XM; Li CY
    FASEB J; 2020 Jun; 34(6):8416-8427. PubMed ID: 32350948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
    An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
    Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
    Nilsson L; Astrand-Grundström I; Arvidsson I; Jacobsson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2000 Sep; 96(6):2012-21. PubMed ID: 10979941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
    Will B; Zhou L; Vogler TO; Ben-Neriah S; Schinke C; Tamari R; Yu Y; Bhagat TD; Bhattacharyya S; Barreyro L; Heuck C; Mo Y; Parekh S; McMahon C; Pellagatti A; Boultwood J; Montagna C; Silverman L; Maciejewski J; Greally JM; Ye BH; List AF; Steidl C; Steidl U; Verma A
    Blood; 2012 Sep; 120(10):2076-86. PubMed ID: 22753872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
    Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
    Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
    Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
    Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.